Pennsylvania HB 1470: An Act amending the act of June 13, 1967 (P.L.31, No.21), known as the Human Services Code, in public assistance, providing for subscription model for GLP-1 agonists.

Bill Text

PRINTER'S NO. 1731
THE GENERAL ASSEMBLY OF PENNSYLVANIA
HOUSE BILL
No. 1470
Session of
2025
INTRODUCED BY VENKAT, CUTLER, RIVERA, HILL-EVANS, HOWARD,
HARKINS, JAMES, SANCHEZ, KHAN, HOHENSTEIN, STEELE,
SHUSTERMAN, FLEMING AND MAYES, MAY 15, 2025
REFERRED TO COMMITTEE ON HUMAN SERVICES, MAY 15, 2025
AN ACT
Amending the act of June 13, 1967 (P.L.31, No.21), entitled "An
act to consolidate, editorially revise, and codify the public
welfare laws of the Commonwealth," in public assistance,
providing for subscription model for GLP-1 agonists.
The General Assembly of the Commonwealth of Pennsylvania
hereby enacts as follows:
Section 1. The act of June 13, 1967 (P.L.31, No.21), known
as the Human Services Code, is amended by adding a section to
read:
Section 449.3. Subscription Model for GLP-1 Agonists.--(a)
The department shall seek a waiver from the Centers for Medicare
and Medicaid Services of the United States Department of Health
and Human Services to permit the Commonwealth to enter into
value-based arrangements with drug manufacturers through
supplemental rebate agreements for GLP-1 agonists used to treat
obesity.
(b) Subject to Federal approval, the department shall
promulgate regulations to implement this section.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18

(c) As used in this section, the following words and phrases
shall have the meanings given to them in this subsection unless
the context clearly indicates otherwise:
"GLP-1 agonist." A type of medication which mimics the
effect of the GLP hormone on the body, including the following
effects:
(1) Triggering insulin release from the pancreas.
(2) Blocking glucagon secretion.
(3) Slowing the emptying of the stomach.
(4) Increasing how full an individual feels after eating.
"Supplemental rebate agreement." An agreement between the
Commonwealth and a drug manufacturer which allows the
Commonwealth to pay an agreed amount per treatment provided up
to a cap, at which point treatments are provided at no cost to
the Commonwealth.
Section 2. This act shall take effect in 60 days.
20250HB1470PN1731 - 2 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16